Abstract: The present invention relates to a nanocarrier for targeted therapy and/or diagnosis of a prostate cancer cell, the nanocarrier including a micelle including a phosphate surfactant represented by a specific Chemical Formula. The micelle including the phosphate surfactant constituting the nanocarrier for targeted therapy and/or diagnosis of the prostate cancer cell according to the present invention is cleaved by the overexpressed enzyme in the vicinity of the prostate cancer cell, so that therapeutic agent or diagnostic agent particles loaded on the micelle are capable of being selectively released to the prostate cancer cell. Therefore, it is possible to maximize the therapeutic and/or diagnostic effects while remarkably reducing the side effects of the drug in the living body compared to a conventional technology.

Abstract: A device for detecting a morpheme tagging corpus error, of the present invention, includes: an attribute generating unit for generating attributes for word phrases included in an input corpus, by using a kernel to which a rough set theory is applied; and an attribute statistics processing unit for generating part-of-speech tagging corpus error data through the calculation of attributes and frequency count for the same word phrases by counting attributes for the same word phrase among the word phrases, and thus the present invention can detect, quantify, and modify errors included in a corpus (learning data) required in learning for classifier generation and recognition for natural language processing.

Abstract: A device for detecting a morpheme tagging corpus error, of the present invention, includes: an attribute generating unit for generating attributes for word phrases included in an input corpus, by using a kernel to which a rough set theory is applied; and an attribute statistics processing unit for generating part-of-speech tagging corpus error data through the calculation of attributes and frequency count for the same word phrases by counting attributes for the same word phrase among the word phrases, and thus the present invention can detect, quantify, and modify errors included in a corpus (learning data) required in learning for classifier generation and recognition for natural language processing.

Abstract: The present invention relates to a nanocarrier for targeted therapy and/or diagnosis of a prostate cancer cell, the nanocarrier including a micelle including a phosphate surfactant represented by a specific Chemical Formula. The micelle including the phosphate surfactant constituting the nanocarrier for targeted therapy and/or diagnosis of the prostate cancer cell according to the present invention is cleaved by the overexpressed enzyme in the vicinity of the prostate cancer cell, so that therapeutic agent or diagnostic agent particles loaded on the micelle are capable of being selectively released to the prostate cancer cell. Therefore, it is possible to maximize the therapeutic and/or diagnostic effects while remarkably reducing the side effects of the drug in the living body compared to a conventional technology.